» Articles » PMID: 22107345

High Throughput Screening: an in Silico Solubility Parameter Approach for Lipids and Solvents in SLN Preparations

Overview
Publisher Informa Healthcare
Specialties Pharmacology
Pharmacy
Date 2011 Nov 24
PMID 22107345
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The present paper describes an in silico solubility behavior of drug and lipids, an essential screening study in preparation of solid lipid nanoparticles (SLN).

Materials And Methods: Ciprofloxacin HCl was selected as a model drug along with 11 lipids and 5 organic solvents. In silico miscibility study of drug/lipid/solvent was performed using Hansen solubility parameter approach calculated by group contribution method of Van Krevelen and Hoftyzer. Predicted solubility was validated by determining solubility of lipids in various solvent at different temperature range, while miscibility of drug in lipids was determined by apparent solubility study and partition experiment.

Results And Discussion: The presence of oxygen and OH functionality increases the polarity and hydrogen bonding possibilities of the compound which has reflected the highest solubility parameter values for Geleol and Capmul MCM C8. Ethyl acetate, Geleol and Capmul MCM C8 was identified as suitable organic solvent, solid lipid and liquid lipid respectively based on a solubility parameter approach which was in agreement with the result of an apparent solubility study and partition coefficient.

Conclusion: These works demonstrate the validity of solubility parameter approach and provide a feasible predictor to the rational selection of excipients in designing SLN formulation.

Citing Articles

Targeting Acne: Development of Monensin-Loaded Nanostructured Lipid Carriers.

Abid F, Kim S, Savaliya B, Cesari L, Amirmostofian M, Abdella S Int J Nanomedicine. 2025; 20:2181-2204.

PMID: 39990290 PMC: 11847435. DOI: 10.2147/IJN.S497108.


Nanoparticle-Mediated Delivery of Micheliolide Analogs to Eliminate Leukemic Stem Cells in the Bone Marrow.

Ackun-Farmmer M, Alwaseem H, Counts M, Bortz A, Giovani S, Frisch B Adv Ther (Weinh). 2022; 5(1).

PMID: 35097186 PMC: 8791645. DOI: 10.1002/adtp.202100100.


Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active.

Sakellari G, Zafeiri I, Batchelor H, Spyropoulos F Food Hydrocoll Health. 2022; 1:None.

PMID: 35028634 PMC: 8721956. DOI: 10.1016/j.fhfh.2021.100024.


Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis.

Etxebeste-Mitxeltorena M, Moreno E, Carvalheiro M, Calvo A, Navarro-Blasco I, Gonzalez-Penas E ACS Infect Dis. 2021; 7(12):3197-3209.

PMID: 34767359 PMC: 8675869. DOI: 10.1021/acsinfecdis.1c00394.


The use of quantitative analysis and Hansen solubility parameter predictions for the selection of excipients for lipid nanocarriers to be loaded with water soluble and insoluble compounds.

Makoni P, Ranchhod J, WaKasongo K, Khamanga S, Walker R Saudi Pharm J. 2020; 28(3):308-315.

PMID: 32194332 PMC: 7078564. DOI: 10.1016/j.jsps.2020.01.010.